Product and Services Finder

Biomarker Discovery

    
<  1  2  3  4  >
Myriad RBM, Inc.  Myriad RBM is a CLIA-certified biomarker testing laboratory specializing in cost-effective, high-quality multiplexing services. Our protein immunoassays benefit drug discovery & development from preclinical through Phase...
 
Services Provided Myriad RBM, Inc. is the world’s leading multiplexed immunoassay testing laboratory, providing comprehensive protein biomarker services based on its...
 
Strategic Biomarker Services Over 11 years of assay development and biomarker expertise have enabled Myriad RBM to grow our menu to more than 250 quantitative human biomarker assays....
United States Biological  USBiological is a long-established biotech manufacturer located near Boston, offering a wide range of biologicals, biochemicals and the largest selection of antibodies you will find anywhere. USBio offers over 100,000...
 
Custom Services: Antibodies Custom Antibody Production
 
Custom Services: Media CS050-01 Custom lots are available should your facility have a specialized formulation. United States Biological will help formulate, blend and test. We will even...
 
Bio-Rad AbD Serotec Limited  With over 30 years of antibody manufacturing experience, AbD Serotec, a Bio-Rad company, is one of the world’s leading antibody suppliers providing high quality reagents and custom services. We offer an extensive range of...
 
Antibody Processing Services AbD Serotec are able to offer a range of custom antibody processing services -Conjugations to various fluorochromes -Freeze drying -Protein...
Confluence Discovery Technologies, Inc.  Confluence is a Contract Research Organization providing Clients with 125+ Years of Drug R&D know-how and a proven track record having delivered 29 Phase I and 21 Phase II drug programs that resulted in 4 marketed...
 
Translational Research full range of capabilities to meet client needs
ImmunoSite Technologies, LLC  Contract Research Services provider of assay automation and product development for the Life Sciences, and particle testing for manufacturing QC.
 
Assay Automation Services For when you have to do more with less by yesterday!
Nuvisan Pharma Services  Bioanalytics, Immunology, Phase I/IIa (CPU) unit, Clinical Trial Supplies, Stability, Analytical, full service Phase II-IV, Pharmaceutical Analytics, Formulation Development, CDM & Biostatistics, and Regulatory Affairs
 
Immunology Immunogenicity testing according to EMA Guidelines: -Assay development, validation and GLP-compliant performance -Screening assays -Confirmatory...
Stemina Biomarker Discovery  Stemina Biomarker Discovery is a metabolomics company focused on the discovery, development and commercialization of molecular biomarkers to improve drug safety and human health. Stemina’s cell based assays arise from...
 
DevTOX™ In a blind study using hES cells as the test substrate and Stemina’s proprietary metabolimics platform to test 27 drugs with known birth-defect-causing...
AltheaDx, Inc.  AltheaDx provides a start-to-finish suite of services focused on molecular biomarker discovery, assay development, assay validation and prospective/retrospective clinical trial testing in support of companion diagnostic...
 
NGS Mutation Panel In coordination with Gynecologic Oncology Group 84th Semi-Annual Meeting in San Diego this week, AltheaDx has announced the launch of a next-generation...
 
NGS Services AltheaDx, Inc. today announced the launch of next-generation sequencing “NGS” services into its clinical molecular pathology lab for application in...
Orion Genomics  Orion Genomics, the Second Code Company, develops epigenetic research tools and molecular diagnostic products to fulfill the promise of personalized medicine. Orion's lead product is a simple blood-based test that is...
 
MethylScope® Orion's patented MethylScope® technology, first published in Nature 2004, enables genome-wide DNA methylation profiling. MethylScope technology is a best in...
 
MethylScreen™ MethylScreen™ technology is a patent pending clinical assay technology. Based on the real-time PCR platform, MethylScreen assays are performed on equipment...
Crown Bioscience  Crown Bioscience is a CRO specialized in oncology: preclinical pharmacology, translational research, xenograft models, human primary tumors, cell based assay screening,predictive biomarker.
Creative Proteomics  Creative Proteomics is the Proteomics division of CD Inc, an integrated CRO company that provides a full range of drug development services, including Molecular Biology, Biochemistry, Systems Biology, Organic Chemistry,...
Integromics  Integromics offers its clients a deep and current understanding of challenges, initiatives and solutions related to Life Sciences. Integromics has formed important partnerships in industry and academia to develop...
 
Integromics Biomarker Discovery® - Microarray analysis Integromics Biomarker Discovery® (IBD) is an easy-to-use bioinformatics application focused on preprocessing, normalization and interpretation of raw...
Virtue Insight Ltd  Biosimilar, Pharmacovigilance,Prefilled Syringe,Anti Counterfeiting, Pricing, Reimbursement, Biomarker
<  1  2  3  4  >
More

Biomarker Discovery Research Library

Myriad RBM, Inc. Document
Myriad RBM, Inc.
Learn how Myriad RBM's biomarker services can help provide a sensitive and early method for the detection of kidney injury. Nephrotoxicity or acute kidney injury is a major problem in both the preclinical and clinical setting that results in the failure of candidate compounds throughout the drug-development cycle. The kidney is particularly susceptible to drug induced toxicity since components ...
 
FACS Technical Brief
Confluence Discovery Technologies, Inc.
TECHNICAL BRIEF: FACS Fluorescence - Activated DISCOVERY TECHNOLOGIES Cell Sorting G G Src FACS FACS is an essential tool for in-depth cell analysis. With GTP G -O the capacity to Gsimultaneously measure multipleSpOaSrameters 3 Fluorescence – G ActivatedPCaxell SorPtYinKg2 on hundreds of individual cells per second, FACS is a power- G -1 GTP ful technology with a wide variety of SaHppClications ...
 
Biopharmaceuticals Safety Assessment
Nuvisan Pharma Services
Preclinical Safety Assessment of Biopharmaceuticals By Dr. Eddy Bruyns, Director Biopharmaceuticals, Nuvisan GmbH The advent of biopharmaceuticals brought new challenges to drug development, both for preclinical and clinical development. Nothing demonstrated this more clearly than the tragic events surrounding the 2006 First-in-Man clinical trial with the superagonistic anti-CD28 monoclonal ...
 
Improving Cryopreservation of PBMC for More Reliable Information From Clinical Trials
ImmunoSite Technologies, LLC
In this document, we discuss a feasibility study that evaluates new methods to improve cryopreservation of PBMC to obtain more reliable information from clinical trials. The increased demand to develop new therapeutic products faster and with minimal side effects has prompted investigators to focus on new predictive tests and patient stratification strategies. As a result, more preclinical and ...
 
Biomarker Discovery and Development
Gene Logic
 

Biomarker Discovery Video

About Us at ImmunoSite Technologies, LLC Document ImmunoSite Technologies, LLC Learn more about contract research services from the management team at ImmunoSite Technologies
 
Learn how Thomson Reuters can help identify disease treatment options Thomson Reuters Systems Biology
 
Biomarker Discovery Bio-Rad AbD Serotec Limited Pharmaceuticals

Biomarker Discovery News

Biomarker Discovery Confluence Discovery Technologies, Inc. Information
Biomarker Discovery ImmunoSite Technologies, LLC Information
Copyright © 2014, Questex Media Group LLC
Company descriptions and contact information are quoted from the company's website or other promotional information. Questex is not responsible for the accuracy of this information. Unless specifically noted, Questex is not sponsored by, affiliated with or otherwise connected with any of the listed companies.